Sign inJoin waitlistJoin the waitlist

Ruta Rao

Director, Coleman Foundation Comprehensive Breast Cancer Clinic · Rush University Medical Center

Credentials: · · ·

History

RUSH University Cancer Center · Rush University Medical Center
Present
Rush University Medical Center
Present
Rush University Medical Center
Present

Hematology and Medical Oncology
Rush University Medical Center
2001–2004
Internal Medicine
University of Illinois College of Medicine at Chicago
1998–2001
University of Wisconsin School of Medicine and Public Health
1994–1998
Northwestern University

Research

Cardiovascular disease in cancer survivors
Review · Postgraduate Medical Journal · 2017 · Last of 3 authors · 82 citations
A community effort to reduce the black/white breast cancer mortality disparity in Chicago
Cancer Causes & Control · 2009 · 65 citations
Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination
Advances in Radiation Oncology · 2019 · Last of 9 authors · 57 citations

Melody Cobleigh
7 papers
Lydia Usha
6 papers
AM
Andrea Madrigrano
3 papers
Cristina O'Donoghue
3 papers · 1 as a fellow
Kent Hoskins
3 papers
Miles Grunvald
3 papers · 3 as a resident
AS
Aimee Schad
2 papers · 2 as a resident
BT
Bita Tabesh
2 papers
Chandler Cortina
2 papers · 1 as a fellow
David Ansell
2 papers
JC
James Coggan
2 papers · 2 as a fellow
Jamile Shammo
2 papers

Clinical trials

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer
Principal investigator · Withdrawn · Phase 1
Rush University Medical Center
2026–2027
Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer
Principal investigator · Terminated · Phase 2
Rush University Medical Center
2007–2011
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
E-Mindfulness Approaches for Living After Breast Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2030